Osteopore (ASX:OSX) secured European Union Medical Device Regulation (EU MDR) approval for its custom orthopedic and cranial implants, according to a Wednesday filing with the Australian bourse.
The approval and the distribution deal with US medical device company Zimmer Biomet allow the company to supply the custom implants to the European market, the filing said.
Osteopore shares surged 200% in afternoon trade Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.